Literature DB >> 23746719

Improved survival with surgery in prostate cancer patients without medical comorbidity: a self-fulfilling prophecy?

Zachary S Zumsteg, Michael J Zelefsky.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23746719     DOI： 10.1016/j.eururo.2013.05.037

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.

Authors:  Joo Yong Lee; Ho Won Kang; Koon Ho Rha; Nam Hoon Cho; Young Deuk Choi; Sung Joon Hong; Kang Su Cho
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-12       Impact factor: 4.553

2.  Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Authors:  Jeff M Michalski; Jennifer Moughan; James Purdy; Walter Bosch; Deborah W Bruner; Jean-Paul Bahary; Harold Lau; Marie Duclos; Matthew Parliament; Gerard Morton; Daniel Hamstra; Michael Seider; Michael I Lock; Malti Patel; Hiram Gay; Eric Vigneault; Kathryn Winter; Howard Sandler
Journal:  JAMA Oncol       Date:  2018-06-14       Impact factor: 31.777

3.  Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice.

Authors:  Agnieszka Lemanska; Rachel C Byford; Clare Cruickshank; David P Dearnaley; Filipa Ferreira; Clare Griffin; Emma Hall; William Hinton; Simon de Lusignan; Julian Sherlock; Sara Faithfull
Journal:  BMC Med Res Methodol       Date:  2020-07-25       Impact factor: 4.615
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.